New study shows smaller biopharma companies struggle more than larger ones with clinical trial transparency

As clinical trial transparency and the sharing of positive and negative trial results slowly become the norm rather than the exception, a new study published in the BMJ¬†revealed struggles from smaller companies to keep up with their larger rivals when it comes to transparency. AbbVie, Amgen, Bayer, Merck KGaA/EMD Serono,…

...

Click to view original post